Prescription for Wellness ~ Leveraging Insurance Carrier Resources to Optimize Patient Engagement Outcomes!

Aug. 2025Education/Webinars

Prescription for Wellness is a nationally recognized, Six Sigma-developed best practice system that provides a convenient and effective way for providers to prescribe resources and support offered by UPMC Health Plan to their patients who are UPMC Health Plan members.

Suzanne Labriola, DO, DipACLM, Senior Medical Director, UPMC Employee Group Medical Director, Prescription for Wellness, UPMC Health Plan and Christine Sheffey, MSW, BCBA, Senior Program Manager, Prescription for Wellness, UPMC Health Plan, host a recorded CME-accredited webinar on the topic of Prescription for Wellness- Supercharging Wellness Engagement and Outcomes through Provider Referral.

At the end of this course attendees should be able to:

  • Describe strategies they can deploy to integrate care across payer and provider with the goal of improving population health outcomes and addressing health care disparities.
  • Explain how to utilize quality measures and data analytics to evaluate the impact of provider-prescribed health coaching and care management on patient-member health, self-care for chronic diseases, and shared decision-making.
  • Define best practice processes to promote strategic implementation and optimization of a patient-member engagement platform.

This course can be accessed via this link

If you are a new user of the UPMC Center for Continuing Education in the Health Sciences (CCEHS) website, you can register after clicking on any of the webinars below, or you can register with the CCEHS now.

The Prescription for Wellness (PFW) operational team is available to help you, and your practice integrate PFW into existing office workflows. To get started, contact the PFW team at RxforWellness@upmc.edu.


Recent Announcements

CME Webinar: The State of Telehealth in 2026

Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.
Dec. 2025Education/Webinars

Formulary updates effective Jan. 1, 2026

Review upcoming policy and operational updates
Dec. 2025Pharmacy Updates

Voluntary nationwide recall: Famotidine (Fresenius – November)

Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.
Nov. 2025Pharmacy Updates